External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 1, 2012, Pages 81-88

  Stavelin, Anne ^a,d   Meijer, Piet ^b   Kitchen, Dianne ^c   Sandberg, Sverre ^d,e  

^a Norwegian Quality Improvement of Primary Care Laboratories (NOKLUS)   (Norway)

^b External Quality Control of Diagnostic Assays and Tests (ECAT Foundation)   (Netherlands)

^c United Kingdom National External Quality Assessment Scheme (UKNEQAS) for Blood Coagulation   (United Kingdom)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anticoagulation treatment; External quality assessment; International normalized ratio; Point of care testing

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; ANTIVITAMIN K; PHENPROCOUMON; WARFARIN;

ANALYTIC METHOD; ANTICOAGULANT THERAPY; ARTICLE; DEVICES; EUROPE; EXTERNAL QUALITY ASSESSMENT; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; PATIENT EDUCATION; PATIENT MONITORING; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTHROMBIN TIME; QUALITY CONTROL; QUESTIONNAIRE; SAMPLE;

EUROPE; HUMANS; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS;

EID: 84857821583     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.719     Document Type: Article

References (35)

1. Perry DJ, Fitzmaurice DA, Kitchen S, Mackie IJ, Mallett S. Point-of-care testing in haemostasis. Br J Haematol 2010;150: 501-14.
2. Favaloro EJ, McVicker W, Hamdam S, Hocker N. Improving the harmonisation of the International Normalized Ratio (INR): time to think outside the box? Clin Chem Lab Med 2010;48: 1079-90.
3. Lippi G, Plebani M, Favaloro EJ, Trenti T. Laboratory testing in pharmacies. Clin Chem Lab Med 2010;48:943-53
4. ISO22870. Point-of-care testing (POCT)-Requirements for quality and competence. International Organization for Standardization, Geneva, Switzerland 2005; Final Draft
5. CLSI. Quality management: approaches to reducing errors at the point of care; approved guideline. Wayne, PA, USA: Clinical and Laboratory Standards Institute, CLSI document POCT07-A 2010
6. NCCLS. Point-of-care monitoring of anticoagulation therapy; approved guideline. Wayne, PA, USA: The National Committee for Clinical Laboratory Standards, NCCLS document H49-A 2004.
7. ISO15189. Medical laboratories-particular requirements for quality and competence. International Organization for Standardization, Geneva, Switzerland 2007.
8. Skurtveit KJ, Bjelkaroy WI, Christensen NG, Thue G, Sandberg S, Hoddevik G. Quality of rapid tests for determination of infectious mononucleosis. Tidsskr Nor Laegeforen 2001;121: 1793-7. (Pubitemid 33708458)
9. Bjelkaroy WI, Sandberg S, Thue G, Digranes A, Hoiby EA, Lermark G, et al. Quality assessment of urine dip-slides in primary care. Tidsskr Nor Laegeforen 2006;126:149-52.
10. Nissinen A, Stranden P, Myllys R, Takkinen J, Bjorkman Y, Leinikki P, et al. Point-of-care testing of group A streptococcal antigen: performance evaluated by external quality assessment. Eur J Clin Microbiol Infect Dis 2009;28:17-20.
11. Morandi PA, Deom A, Mauris A, Rohner P. External quality control of direct antigen tests to detect group A streptococcal antigen. Eur J Clin Microbiol Infect Dis 2003;22:670-4. (Pubitemid 37491620)
12. Van Blerk M, Coucke W, Chatelain B, Goossens W, Jochmans K, Meeus K, et al. External quality assessment in the measurement of haemoglobin by blood gas analysers in Belgium. Scand J Clin Lab Invest 2007;67:735-40. (Pubitemid 350034636)
13. Wood WG. Problems and practical solutions in the external quality control of point of care devices with respect to the measurement of blood glucose. J Diabetes Sci Technol 2007; 1:158-63.
14. Kitchen S, Kitchen DP, Jennings I, Woods TA, Walker ID, Preston FE. Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors. Thromb Haemostasis 2006;96: 590-6. (Pubitemid 44782538)
15. Kessler P. External quality assessment of prothrombin time testing on POCT monitor. wCzechx. Klinicka Biochemie a Meta-bolismus 2010;18:210-3.
16. Meijer P, Kluft C, Poller L, van der Meer FJ, Keown M, Ibrahim S, et al. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors. Am J Clin Pathol 2006;126:756-61. (Pubitemid 44707627)
17. Solvik UO, Stavelin A, Christensen NG, Sandberg S. External quality assessment of prothrombin time: the split-sample model compared with external quality assessment with commercial control material. Scand J Clin Lab Invest 2006;66:337-49.
18. EQALM. European Organization for External Quality Assurance in Laboratory Medicine. http://www.eqalm.org.
19. UN. United Nations Statistics Division. http://unstats.un.org.
20. Klee GG, Westgard JO. Quality Management. In: Burtis CA, Ashwood ER, Bruns DE, editors. Tietz fundamentals of clinical chemistry, 6th ed. Oxford, UK: Elsevier Saunders 2008:249-62.
21. Miller WG, Erek A, Cunningham TD, Oladipo O, Scott MG, Johnson RE. Commutability limitations influence quality control results with different reagent lots. Clin Chem 2011;57: 76-83.
22. van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolys 2001;12:35-40. (Pubitemid 33103840)
23. Spannagl M, Dick A, Reinauer H. External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome. Semin Thromb Hemost 2007;33:259-64. (Pubitemid 46581380)
24. CLSI. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline, 5th ed. Wayne, PA, USA: Clinical and Laboratory Standards Institute, CLSI document H21-A5 2008.
25. Kitchen D, Murray E, Kitchen S, Jennings I, Fitzmaurice D, Woods T, et al. External quality assessment for prothrombin time/international normalised ratio using point-of-care devices: split-sample or conventional external quality assessment using control samples? Scand J Clin Lab Invest 2007;67:673-5. (Pubitemid 350034635)
26. Solvik UO, Stavelin A, Christensen NG, Sandberg S. Response to Kitchen et al.'s external quality assessment of prothrombin time: the split-sample model compared to external quality assessment with commercial control material. Scand J Clin Lab Invest 2007;67:676-7. (Pubitemid 350034634)
27. Poller L, Keown M, Chauhan N, van den Besselaar AM, Tri-podi A, Shiach C, et al. European concerted action on anticoagulation. Quality assessment of the CoaguChek Mini and TAS PT-NC point-of-care whole-blood prothrombin time monitors. Clin Chem 2004;50:537-44. (Pubitemid 38297303)
28. Guideline of the Federal Medical Association on Quality Assurance of Quantitative Analyses in Laboratory Medicine. Dtsch Ärztebl 2001;98:A2747-59.
29. Stavelin A, Petersen PH, Solvik U, Sandberg S. Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thromb Haemostasis 2009;102:593-600.
30. Parvin CA, Gronowski AM. Effect of analytical run length on quality-control (QC) performance and the QC planning process. Clin Chem 1997;43:2149-54. (Pubitemid 27497815)
31. Kenny D, Fraser CG, Petersen PH, Kallner A. Consensus agreement. Scand J Clin Lab Invest 1999;59:585. (Pubitemid 30056757)
32. Klee GG. Establishment of outcome-related analytic performance goals. Clin Chem 2010;56:714-22.
33. Skeie S, Perich C, Ricos C, Araczki A, Horvath AR, Oosterhuis WP, et al. Postanalytical external quality assessment of blood glucose and hemoglobin A1c: an international survey. Clin Chem 2005;51:1145-53. (Pubitemid 43079391)
34. Kristoffersen AH, Thue G, Sandberg S. Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clin Chem 2006;52:1871-8. (Pubitemid 44470694)
35. Aakre KM, Thue G, Subramaniam-Haavik S, Bukve T, Morris H, Muller M, et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. Clin Chem 2008;54:1630-6.